ARCHIVES

In Congress: Time Running out On Effort To Double Market Exclusivity Term

This article is from The Cancer Letter archive.

Vol. 23 No. 43 | November 7, 1997

Download PDF Visit The Full Archive

Related Articles

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program

October 8, 1999

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

Also Weber returns to M.D. Anderson.

August 8, 2003